Ultragenyx Pharmaceutical reported $-151833000 in Net Income for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Acadia Pharmaceuticals ACAD:US USD -41725000 14.54M
Agios Pharmaceuticals AGIO:US USD 36.53M 118.27M
Alnylam Pharmaceuticals ALNY:US USD -207493000 198.43M
Aptinyx Inc APTX:US USD -15303000 2.36M
Biocryst Pharmaceuticals BCRX:US USD -71541000 29.02M
Biomarin Pharmaceutical BMRN:US USD -249000 6.4M
Bluebird Bio BLUE:US USD -76520000 23.62M
Esperion Therapeutics ESPR:US USD -55487000 370K
Insmed INSM:US USD -160123000 28.98M
Karyopharm Therapeutics KPTI:US USD -38506000 2.18M
Kyowa Hakko Kirin 4151:JP JPY 4.36B 9.84B
Macrogenics MGNX:US USD 12.8M 37.61M
Mirati Therapeutics MRTX:US USD -202475000 28.91M
Moderna Inc MRNA:US USD 1.46B 422M
Neurocrine Biosciences NBIX:US USD 89M 20.5M
Ptc Therapeutics PTCT:US USD -170889000 61.57M
Puma Biotechnology PBYI:US USD -5606000 5.25M
Regeneron Pharmaceuticals REGN:US USD 1.2B 118.6M
Sarepta Therapeutics SRPT:US USD -109244000 148.49M
Ultragenyx Pharmaceutical RARE:US USD -151833000 93.27M
Vertex Pharmaceuticals VRTX:US USD 818.9M 111.6M
Vital Therapies VTL:US USD -56474000 35.25M
Xoma XOMA:US USD -5976000 1.8M